All lobbying filings

AVENUE SOLUTIONS

Lobbying for INCYTE CORPORATION · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate · $60,000.00 income · posted Jul 20, 2026

Official filing document

Lobbying activity 2

Health Issues

Issues related to 340b

Medicare/Medicaid

Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE)); Issues related to Senate Finance Dear Colleague process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.